मूलभूत आँकड़े
| CIK | 1852749 |
SEC Filings
All companies that sell securities in the United States must register with the Securities and Exchange Commission (SEC) and file reports on a regular basis.
These reports include company annual reports (10K, 10Q), news updates (8K), investor presentations (found in 8Ks), insider trades (form 4), ownership reports (13D, and 13G), and reports related to the specific securities sold, such as registration statements and prospectus. This page shows recent SEC filings related to ExcelFin Acquisition Corp.
SEC Filings (Chronological Order)
यह पृष्ठ SEC फाइलिंग की एक पूरी, कालानुक्रमिक सूची प्रदान करता है, ओनरशिप फाइलिंग को छोड़कर, जो हम अन्यत्र प्रदान करते हैं।
| October 11, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 15 CERTIFICATION AND NOTICE OF TERMINATION OF REGISTRATION UNDER SECTION 12(g) OF THE SECURITIES EXCHANGE ACT OF 1934 OR SUSPENSION OF DUTY TO FILE REPORTS UNDER SECTIONS 13 AND 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934. Commission File Number 001-40933 EXCELFIN ACQUISITION CORP. (Exact name of registrant as specified |
|
| September 27, 2024 |
Financial Statements and Exhibits, Other Events UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): September 27, 2024 ExcelFin Acquisition Corp. (Exact name of registrant as specified in its charter) Delaware 001-40933 86-2933776 (State or other jurisdiction of incorporation) (Comm |
|
| September 26, 2024 |
Financial Statements and Exhibits, Submission of Matters to a Vote of Security Holders UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): September 26, 2024 ExcelFin Acquisition Corp. (Exact name of registrant as specified in its charter) Delaware 001-40933 86-2933776 (State or other jurisdiction of incorporation) (Comm |
|
| September 12, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): September 11, 2024 ExcelFin Acquisition Corp. (Exact name of registrant as specified in its charter) Delaware 001-40933 86-2933776 (State or other jurisdiction of incorporation) (Comm |
|
| September 5, 2024 |
Regulation FD Disclosure, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): September 5, 2024 ExcelFin Acquisition Corp. (Exact name of registrant as specified in its charter) Delaware 001-40933 86-2933776 (State or other jurisdiction of incorporation) (Commi |
|
| September 5, 2024 |
DEFM14A 1 tm2423377-1defm14a.htm DEFM14A TABLE OF CONTENTS UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential for Use of the Commission Only (as p |
|
| September 5, 2024 |
Baird Medical and ExcelFin Acquisition Corp Announce Effectiveness of Registration Statement Exhibit 99.1 Baird Medical and ExcelFin Acquisition Corp Announce Effectiveness of Registration Statement FORT MILL, S.C., September 5, 2024 /PRNewswire/ - Betters Medical Investment Holdings Limited ("Baird Medical" or the "Company"), a leading microwave ablation ("MWA") medical device developer and provider in China, and ExcelFin Acquisition Corp. ("ExcelFin") (NASDAQ: XFIN), a publicly traded s |
|
| September 5, 2024 |
Baird Medical and ExcelFin Acquisition Corp Announce Effectiveness of Registration Statement Exhibit 99.1 Baird Medical and ExcelFin Acquisition Corp Announce Effectiveness of Registration Statement FORT MILL, S.C., September 5, 2024 /PRNewswire/ - Betters Medical Investment Holdings Limited ("Baird Medical" or the "Company"), a leading microwave ablation ("MWA") medical device developer and provider in China, and ExcelFin Acquisition Corp. ("ExcelFin") (NASDAQ: XFIN), a publicly traded s |
|
| September 5, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): September 5, 2024 ExcelFin Acquisition Corp. (Exact name of registrant as specified in its charter) Delaware 001-40933 86-2933776 (State or other jurisdiction of incorporation) (Commi |
|
| August 23, 2024 |
FOURTH AMENDMENT TO THE BUSINESS COMBINATION AGREEMENT Exhibit 2.1 FOURTH AMENDMENT TO THE BUSINESS COMBINATION AGREEMENT This Fourth Amendment to the Business Combination Agreement (this “Amendment”) is entered into as of August 23, 2024, by and among (a) ExcelFin Acquisition Corp., a Delaware corporation (“SPAC”), (b) Betters Medical Investment Holdings Limited, a Cayman Islands exempted company (“Betters”), (c) Baird Medical Investment Holdings Lim |
|
| August 23, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): August 23, 2024 ExcelFin Acquisition Corp. (Exact name of registrant as specified in its charter) Delaware 001-40933 86-2933776 (State or other jurisdiction of incorporation) (Commiss |
|
| August 23, 2024 |
FOURTH AMENDMENT TO THE BUSINESS COMBINATION AGREEMENT Exhibit 2.1 FOURTH AMENDMENT TO THE BUSINESS COMBINATION AGREEMENT This Fourth Amendment to the Business Combination Agreement (this “Amendment”) is entered into as of August 23, 2024, by and among (a) ExcelFin Acquisition Corp., a Delaware corporation (“SPAC”), (b) Betters Medical Investment Holdings Limited, a Cayman Islands exempted company (“Betters”), (c) Baird Medical Investment Holdings Lim |
|
| August 23, 2024 |
Entry into a Material Definitive Agreement, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): August 23, 2024 ExcelFin Acquisition Corp. (Exact name of registrant as specified in its charter) Delaware 001-40933 86-2933776 (State or other jurisdiction of incorporation) (Commiss |
|
| August 19, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (MARK ONE) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarter ended June 30, 2024 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 001-40933 EXCE |
|
| August 15, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 SEC File Number 001-40933 CUSIP Number 30069X102 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D. |
|
| July 24, 2024 |
Amended and Restated Promissory Note Exhibit 10.1 THIS PROMISSORY NOTE (“NOTE”) HAS NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”). THIS NOTE HAS BEEN ACQUIRED FOR INVESTMENT ONLY AND MAY NOT BE SOLD, TRANSFERRED OR ASSIGNED IN THE ABSENCE OF REGISTRATION OF THE RESALE THEREOF UNDER THE SECURITIES ACT OR AN OPINION OF COUNSEL REASONABLY SATISFACTORY IN FORM, SCOPE AND SUBSTANCE TO THE COMPANY |
|
| July 24, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): July 24, 2024 ExcelFin Acquisition Corp. (Exact name of registrant as specified in its charter) Delaware 001-40933 86-2933776 (State or other jurisdiction of incorporation) (Commissio |
|
| July 17, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant x Filed by a Party other than the Registrant ¨ Check the appropriate box: ¨ Preliminary Proxy Statement ¨ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ¨ Definitive Proxy State |
|
| June 27, 2024 |
Regulation FD Disclosure, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): June 27, 2024 ExcelFin Acquisition Corp. (Exact name of registrant as specified in its charter) Delaware 001-40933 86-2933776 (State or other jurisdiction of incorporation) (Commissio |
|
| June 27, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): June 27, 2024 ExcelFin Acquisition Corp. (Exact name of registrant as specified in its charter) Delaware 001-40933 86-2933776 (State or other jurisdiction of incorporation) (Commissio |
|
| June 27, 2024 |
Exhibit 99.1 Minimally Invasive Medical Technology for Tumor Removal INVESTOR PRESENTATION JUNE 2024 Traditional Method Baird Medical Method Baird Medical This presentation (together with oral statements made in connection herewith, this “Presentation”) is for informational purposes only to assist interested parties in making their own evaluation with respect to the proposed business combination ( |
|
| June 27, 2024 |
Exhibit 99.1 Minimally Invasive Medical Technology for Tumor Removal INVESTOR PRESENTATION JUNE 2024 Traditional Method Baird Medical Method Baird Medical This presentation (together with oral statements made in connection herewith, this “Presentation”) is for informational purposes only to assist interested parties in making their own evaluation with respect to the proposed business combination ( |
|
| June 25, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ☒ Definitive Proxy Statement |
|
| June 20, 2024 |
Exhibit 2.1 THIRD AMENDMENT TO THE BUSINESS COMBINATION AGREEMENT This Third Amendment to the Business Combination Agreement (this “Amendment”) is entered into as of June 17, 2024, by and among (a) ExcelFin Acquisition Corp., a Delaware corporation (“SPAC”), (b) Betters Medical Investment Holdings Limited, a Cayman Islands exempted company (“Betters”), (c) Baird Medical Investment Holdings L |
|
| June 20, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 20, 2024 (June 17, 2024) ExcelFin Acquisition Corp. (Exact name of registrant as specified in its charter) Delaware 001-40933 86-2933776 (State or other jurisdiction of incorpora |
|
| June 20, 2024 |
Entry into a Material Definitive Agreement, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 20, 2024 (June 17, 2024) ExcelFin Acquisition Corp. (Exact name of registrant as specified in its charter) Delaware 001-40933 86-2933776 (State or other jurisdiction of incorpora |
|
| June 20, 2024 |
Exhibit 2.1 THIRD AMENDMENT TO THE BUSINESS COMBINATION AGREEMENT This Third Amendment to the Business Combination Agreement (this “Amendment”) is entered into as of June 17, 2024, by and among (a) ExcelFin Acquisition Corp., a Delaware corporation (“SPAC”), (b) Betters Medical Investment Holdings Limited, a Cayman Islands exempted company (“Betters”), (c) Baird Medical Investment Holdings L |
|
| June 18, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☒ Preliminary Proxy Statement ☐ Confidential for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ☐ Definitive Proxy Statement |
|
| June 18, 2024 |
June 18, 2024 VIA EDGAR Kibum Park Isabel Rivera United States Securities and Exchange Commission Division of Corporation Finance 100 F Street, N. |
|
| June 18, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☒ Preliminary Proxy Statement ☐ Confidential for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ☐ Definitive Proxy Statement |
|
| June 12, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☒ Preliminary Proxy Statement ☐ Confidential for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ☐ Definitive Proxy Statement |
|
| May 16, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 16, 2024 ExcelFin Acquisition Corp. (Exact name of registrant as specified in its charter) Delaware 001-40933 86-2933776 (State or other jurisdiction of incorporation) (Commission |
|
| May 16, 2024 |
Exhibit 2.1 SECOND AMENDMENT TO THE BUSINESS COMBINATION AGREEMENT This Second Amendment to the Business Combination Agreement (this “Amendment”) is entered into as of May 16, 2024, by and among (a) ExcelFin Acquisition Corp., a Delaware corporation (“SPAC”), (b) Betters Medical Investment Holdings Limited, a Cayman Islands exempted company (“Betters”), (c) Baird Medical Investment Holdings Limite |
|
| May 16, 2024 |
Exhibit 2.1 SECOND AMENDMENT TO THE BUSINESS COMBINATION AGREEMENT This Second Amendment to the Business Combination Agreement (this “Amendment”) is entered into as of May 16, 2024, by and among (a) ExcelFin Acquisition Corp., a Delaware corporation (“SPAC”), (b) Betters Medical Investment Holdings Limited, a Cayman Islands exempted company (“Betters”), (c) Baird Medical Investment Holdings Limite |
|
| May 16, 2024 |
Entry into a Material Definitive Agreement, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 16, 2024 ExcelFin Acquisition Corp. (Exact name of registrant as specified in its charter) Delaware 001-40933 86-2933776 (State or other jurisdiction of incorporation) (Commission |
|
| May 14, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (MARK ONE) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarter ended March 31, 2024 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 001-40933 EXC |
|
| April 25, 2024 |
Amended and Restated Promissory Note Exhibit 10.1 THIS PROMISSORY NOTE (“NOTE”) HAS NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”). THIS NOTE HAS BEEN ACQUIRED FOR INVESTMENT ONLY AND MAY NOT BE SOLD, TRANSFERRED OR ASSIGNED IN THE ABSENCE OF REGISTRATION OF THE RESALE THEREOF UNDER THE SECURITIES ACT OR AN OPINION OF COUNSEL REASONABLY SATISFACTORY IN FORM, SCOPE AND SUBSTANCE TO THE COMPANY |
|
| April 25, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): April 25, 2024 ExcelFin Acquisition Corp. (Exact name of registrant as specified in its charter) Delaware 001-40933 86-2933776 (State or other jurisdiction of incorporation) (Commissi |
|
| April 22, 2024 |
Press Release, dated April 22, 2024. Exhibit 99.1 FOR IMMEDIATE RELEASE ExcelFin Acquisition Corp. Announces Increase in Extension Payment New York, NY, April 22, 2024– ExcelFin Acquisition Corp. (“we”, “us”, “our”, or the “Company”), today announced that the special meeting of the stockholders of the Company originally scheduled for April 18, 2024 (the “Special Meeting”) has been postponed to 10:00 a.m. Eastern time on April 25, 202 |
|
| April 22, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant x Filed by a Party other than the Registrant ¨ Check the appropriate box: ¨ Preliminary Proxy Statement ¨ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ¨ Definitive Proxy State |
|
| April 22, 2024 |
Proposed Amendment to Third Amended Certificate of Incorporation of ExcelFin Acquisition Corp. Exhibit 3.1 PROPOSED THIRD AMENDMENT TO THE AMENDED AND RESTATED CERTIFICATE OF INCORPORATION OF EXCELFIN ACQUISITION CORP. ExcelFin Acquisition Corp. (the “Corporation”), a corporation organized and existing under the laws of the State of Delaware, does hereby certify as follows: 1. The name of the Corporation is “ExcelFin Acquisition Corp.” The original certificate of incorporation of the Corpor |
|
| April 12, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): April 10, 2024 ExcelFin Acquisition Corp. (Exact name of registrant as specified in its charter) Delaware 001-40933 86-2933776 (State or other jurisdiction of incorporation) (Commissi |
|
| April 11, 2024 |
Press Release, dated April 11, 2024. Exhibit 99.1 FOR IMMEDIATE RELEASE ExcelFin Acquisition Corp. Announces 30-day Extension of Extension Proposal New York, NY, April 11, 2024 — ExcelFin Acquisition Corp. (“we”, “us”, “our”, or the “Company”), today announced that (i) the special meeting of the stockholders of the Company originally scheduled for April 18, 2024 (the “Special Meeting”) has been adjourned to April 23, 2024 and (ii) th |
|
| April 11, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ☐ Definitive Proxy State |
|
| April 11, 2024 |
Proposed Amendment to Third Amended Certificate of Incorporation of ExcelFin Acquisition Corp. Exhibit 3.1 PROPOSED THIRD AMENDMENT TO THE AMENDED AND RESTATED CERTIFICATE OF INCORPORATION OF EXCELFIN ACQUISITION CORP. ExcelFin Acquisition Corp. (the “Corporation”), a corporation organized and existing under the laws of the State of Delaware, does hereby certify as follows: 1. The name of the Corporation is “ExcelFin Acquisition Corp.” The original certificate of incorporation of the Corpor |
|
| March 22, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ☒ Definitive Proxy Statement |
|
| March 18, 2024 |
Exhibit 99.1 Minimally Invasive Medical Technology for Tumor Removal INVESTOR PRESENTATION MARCH 2024 Traditional Method Baird Medical Method Baird Medical This presentation (together with oral statements made in connection herewith, this “Presentation”) is for informational purposes only to assist interested parties in making their own evaluation with respect to the proposed business combination |
|
| March 18, 2024 |
Regulation FD Disclosure, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 18, 2024 ExcelFin Acquisition Corp. (Exact name of registrant as specified in its charter) Delaware 001-40933 86-2933776 (State or other jurisdiction of incorporation) (Commissi |
|
| March 18, 2024 |
Exhibit 99.1 Minimally Invasive Medical Technology for Tumor Removal INVESTOR PRESENTATION MARCH 2024 Traditional Method Baird Medical Method Baird Medical This presentation (together with oral statements made in connection herewith, this “Presentation”) is for informational purposes only to assist interested parties in making their own evaluation with respect to the proposed business combination |
|
| March 18, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 18, 2024 ExcelFin Acquisition Corp. (Exact name of registrant as specified in its charter) Delaware 001-40933 86-2933776 (State or other jurisdiction of incorporation) (Commissi |
|
| March 14, 2024 |
Exhibit 97.1 EXCELFIN ACQUISITION CORP. DODD-FRANK CLAWBACK POLICY The Board of Directors (the “Board”) of ExcelFin Acquisition Corp., a Delaware corporation (the “Company”) has adopted this Dodd-Frank Clawback Policy (this “Policy”) in accordance with the applicable provisions of The Nasdaq Stock Market LLC Listing Rules (the “Clawback Rules”), promulgated pursuant to the final rules adopted by t |
|
| March 14, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2023 Or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 001-409 |
|
| March 14, 2024 |
Amended and Restated Certificate of Incorporation. Exhibit 3.1 Delaware The First State Page 1 I, JEFFREY W. BULLOCK, SECRETARY OF STATE OF THE STATE OF DELAWARE, DO HEREBY CERTIFY THE ATTACHED IS A TRUE AND CORRECT COPY OF THE RESTATED CERTIFICATE OF “EXCELFIN ACQUISITION CORP.”, FILED IN THIS OFFICE ON THE TWENTIETH DAY OF OCTOBER, A.D. 2021, AT 6:22 O`CLOCK P.M. 5500726 8100 SR# 20213570004 Authentication: 204468011 Date: 10-20-21 You may verif |
|
| March 12, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 12, 2024 ExcelFin Acquisition Corp. (Exact name of registrant as specified in its charter) Delaware 001-40933 86-2933776 (State or other jurisdiction of incorporation) (Commissi |
|
| March 12, 2024 |
Exhibit 99.1 Baird Medical and ExcelFin Acquisition Corp Announce Strategic Update to Business Combination Terms to Reinforce Long-Term Value Creation Opportunity and Alignment with Shareholders · Baird Medical agreed to subject 30% of its shares to be received in the transaction to an earnout at a $12.50 trading price · Minimum cash condition of $15 million has been waived, cementing certainty an |
|
| March 12, 2024 |
Exhibit 99.1 Baird Medical and ExcelFin Acquisition Corp Announce Strategic Update to Business Combination Terms to Reinforce Long-Term Value Creation Opportunity and Alignment with Shareholders · Baird Medical agreed to subject 30% of its shares to be received in the transaction to an earnout at a $12.50 trading price · Minimum cash condition of $15 million has been waived, cementing certainty an |
|
| March 12, 2024 |
Exhibit 2.1 FIRST AMENDMENT TO THE BUSINESS COMBINATION AGREEMENT This First Amendment to the Business Combination Agreement (this “Amendment”) is entered into as of March 11, 2024, by and among (a) ExcelFin Acquisition Corp., a Delaware corporation (“SPAC”), (b) Betters Medical Investment Holdings Limited, a Cayman Islands exempted company (“Betters”), (c) Baird Medical Investment Holdings Limite |
|
| March 12, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 12, 2024 ExcelFin Acquisition Corp. (Exact name of registrant as specified in its charter) Delaware 001-40933 86-2933776 (State or other jurisdiction of incorporation) (Commissi |
|
| March 12, 2024 |
Exhibit 2.1 FIRST AMENDMENT TO THE BUSINESS COMBINATION AGREEMENT This First Amendment to the Business Combination Agreement (this “Amendment”) is entered into as of March 11, 2024, by and among (a) ExcelFin Acquisition Corp., a Delaware corporation (“SPAC”), (b) Betters Medical Investment Holdings Limited, a Cayman Islands exempted company (“Betters”), (c) Baird Medical Investment Holdings Limite |
|
| March 11, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☒ Preliminary Proxy Statement ☐ Confidential for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ☐ Definitive Proxy Statement |
|
| February 14, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G* (Rule 13d-102) INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO § 240.13d-1(b), (c), AND (d) AND AMENDMENTS THERETO FILED PURSUANT TO § 240.13d-2 (Amendment No. 1) ExcelFin Acquisition Corp. (Name of Issuer) Class A ordinary shares, par value $0.0001 per share (Title of Class of Securities) 30069X102 (C |
|
| February 14, 2024 |
US30069X1028 / ExcelFin Acquisition Corp. / Sculptor Capital LP - SC 13G/A Passive Investment SC 13G/A 1 d779913dsc13ga.htm SC 13G/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 3)* EXCELFIN ACQUISITION CORP. (Name of Issuer) Class A Common Stock, par value $0.0001 per share (Title of Class of Securities) 30069X102 (CUSIP Number) December 31, 2023 (Date of Event Which Requires Filing of this St |
|
| February 9, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G/A Under the Securities Exchange Act of 1934 (Amendment No. 1)* ExcelFin Acquisition Corp (Name of Issuer) Common Stock, $0.0001 par value (Title of Class of Securities) 30069X102 (CUSIP Number) December 31, 2023 (Date of Event which Requires Filing of this Statement) Check the appropriate box to designate the rule |
|
| January 26, 2024 |
Regulation FD Disclosure, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): January 26, 2024 ExcelFin Acquisition Corp. (Exact name of registrant as specified in its charter) Delaware 001-40933 86-2933776 (State or other jurisdiction of incorporation) (Commis |
|
| January 26, 2024 |
Exhibit 99.1 Minimally Invasive Medical Technology for Tumor Removal INVESTOR PRESENTATION JANUARY 2024 Traditional Method Baird Medical Method Baird Medical This presentation (together with oral statements made in connection herewith, this “Presentation”) is for informational purposes only to assist interested parties in making their own evaluation with respect to the proposed business combinatio |
|
| December 12, 2023 |
Exhibit 99.1 Minimally Invasive Medical Technology for Tumor Removal INVESTOR PRESENTATION DECEMBER 2023 Traditional Method Baird Medical Method Baird Medical This presentation (together with oral statements made in connection herewith, this “Presentation”) is for informational purposes only to assist interested parties in making their own evaluation with respect to the proposed business combinati |
|
| December 12, 2023 |
Regulation FD Disclosure, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): December 12, 2023 ExcelFin Acquisition Corp. (Exact name of registrant as specified in its charter) Delaware 001-40933 86-2933776 (State or other jurisdiction of incorporation) (Commi |
|
| November 22, 2023 |
Baird Medical Attains FDA Clearance to Market Its Microwave Ablation System in the United States Filed by Baird Medical Investment Holdings Limited and ExcelFin Acquisition Corp. Pursuant to Rule 425 under the Securities Act of 1933 and deemed filed pursuant to Rule 14a-12 under the Securities Exchange Act of 1934 Subject Company: ExcelFin Acquisition Corp. Commission File No.: 001-40933 Date: August 1, 2023 Baird Medical Attains FDA Clearance to Market Its Microwave Ablation System in the Un |
|
| November 20, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (MARK ONE) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarter ended September 30, 2023 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 001-40933 |
|
| November 14, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 SEC File Number 001-40933 CUSIP Number 30069X102 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D. |
|
| November 1, 2023 |
Amended and Restated Promissory Note Exhibit 10.1 THIS PROMISSORY NOTE (“NOTE”) HAS NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”). THIS NOTE HAS BEEN ACQUIRED FOR INVESTMENT ONLY AND MAY NOT BE SOLD, TRANSFERRED OR ASSIGNED IN THE ABSENCE OF REGISTRATION OF THE RESALE THEREOF UNDER THE SECURITIES ACT OR AN OPINION OF COUNSEL REASONABLY SATISFACTORY IN FORM, SCOPE AND SUBSTANCE TO THE COMPANY |
|
| November 1, 2023 |
Exhibit 10.2 AMENDMENT TO THE INVESTMENT MANAGEMENT TRUST AGREEMENT THIS AMENDMENT NO. 1 TO THE INVESTMENT MANAGEMENT TRUST AGREEMENT (this “Amendment”) is made as of October 26, 2023, by and between ExcelFin Acquisition Corp., a Delaware corporation (the “Company”), and U.S. Bank National Association, a national banking association (the “Trustee”). Capitalized terms contained in this Amendment, b |
|
| November 1, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 1, 2023 (October 26, 2023) ExcelFin Acquisition Corp. (Exact name of registrant as specified in its charter) Delaware 001-40933 86-2933776 (State or other jurisdiction of inc |
|
| October 26, 2023 |
Financial Statements and Exhibits, Submission of Matters to a Vote of Security Holders UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): October 26, 2023 (October 20, 2023) ExcelFin Acquisition Corp. (Exact name of registrant as specified in its charter) Delaware 001-40933 86-2933776 (State or other jurisdiction of inc |
|
| October 17, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant x Filed by a Party other than the Registrant ¨ Check the appropriate box: ¨ Preliminary Proxy Statement ¨ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ¨ Definitive Proxy State |
|
| September 26, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ☒ Definitive Proxy Statement |
|
| September 6, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☒ Preliminary Proxy Statement ☐ Confidential for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ☐ Definitive Proxy Statement |
|
| August 11, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (MARK ONE) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarter ended June 30, 2023 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 001-40933 EXCE |
|
| August 1, 2023 |
Filed by Baird Medical Investment Holdings Limited and ExcelFin Acquisition Corp. Filed by Baird Medical Investment Holdings Limited and ExcelFin Acquisition Corp. Pursuant to Rule 425 under the Securities Act of 1933 and deemed filed pursuant to Rule 14a-12 under the Securities Exchange Act of 1934 Subject Company: ExcelFin Acquisition Corp. Commission File No.: 001-40933 Date: August 1, 2023 Baird Medical’s microwave ablation needle approved for thyroid nodules BioWorld July |
|
| August 1, 2023 |
Filed by Baird Medical Investment Holdings Limited and ExcelFin Acquisition Corp. Filed by Baird Medical Investment Holdings Limited and ExcelFin Acquisition Corp. Pursuant to Rule 425 under the Securities Act of 1933 and deemed filed pursuant to Rule 14a-12 under the Securities Exchange Act of 1934 Subject Company: ExcelFin Acquisition Corp. Commission File No.: 001-40933 Date: August 1, 2023 Baird Medical’s microwave ablation needle approved for thyroid nodules BioWorld July |
|
| June 28, 2023 |
Bank of America Tower 800 Capitol Street, Suite 2200 Houston, Texas 77002 Bank of America Tower 800 Capitol Street, Suite 2200 Houston, Texas 77002 +1.713.354.4900 July 28, 2023 Via EDGAR (Correspondence) and Courier Sondra Snyder Staff Accountant Division of Corporation Finance Office of Energy & Transportation U.S. Securities and Exchange Commission 100 F Street, N.E. Washington, D.C. 20549 U.S.A. Re: ExcelFin Acquisition Corp. (the “Company”) Form 10-K for the Fiscal |
|
| June 26, 2023 |
Filed by Baird Medical Investment Holdings Limited Filed by Baird Medical Investment Holdings Limited Pursuant to Rule 425 under the Securities Act of 1933 and deemed filed pursuant to Rule 14a-12 under the Securities Exchange Act of 1934 Subject Company: ExcelFin Acquisition Corp. |
|
| June 26, 2023 |
Exhibit 10.1 BETTERS SHAREHOLDER SUPPORT AGREEMENT This BETTERS SHAREHOLDER SUPPORT AGREEMENT (this “Agreement”) is made and entered into as of June 26, 2023, by and among Betters Medical Investment Holdings Limited, a Cayman Islands exempted company (“Betters”), Baird Medical Investment Holdings Limited, a Cayman Islands exempted company and a direct, wholly owned Subsidiary of Betters (“PubC |
|
| June 26, 2023 |
Exhibit 2.1 BUSINESS COMBINATION AGREEMENT by and among EXCELFIN ACQUISITION CORP., BETTERS MEDICAL INVESTMENT HOLDINGS LIMITED, Baird Medical Investment Holdings Limited, Betters Medical Merger Sub, Inc. and TYCOON CHOICE GLOBAL LIMITED dated as of June 26, 2023 *Certain exhibits and the schedules to this Exhibit have been omitted in accordance with Regulation S-K Item 601(a)(5). The Registrant a |
|
| June 26, 2023 |
Exhibit 10.2 SPONSOR SUPPORT AGREEMENT THIS SPONSOR SUPPORT AGREEMENT, dated as of June 26, 2023 (this “Agreement”), is made and entered into by and among ExcelFin SPAC LLC, a Delaware limited liability company (the “Sponsor”), ExcelFin Acquisition Corp., a Delaware corporation (“SPAC”), and Baird Medical Investment Holdings Limited, a Cayman Islands exempted company (“PubCo”). WHEREAS, SPAC |
|
| June 26, 2023 |
Exhibit 10.1 BETTERS SHAREHOLDER SUPPORT AGREEMENT This BETTERS SHAREHOLDER SUPPORT AGREEMENT (this “Agreement”) is made and entered into as of June 26, 2023, by and among Betters Medical Investment Holdings Limited, a Cayman Islands exempted company (“Betters”), Baird Medical Investment Holdings Limited, a Cayman Islands exempted company and a direct, wholly owned Subsidiary of Betters (“PubC |
|
| June 26, 2023 |
Exhibit 10.3 June 26, 2023 ExcelFin Acquisition Corp. 473 Jackson St., Suite 300 San Francisco, California 94111 Re: Insider Letter Amendment Ladies and Gentlemen: This amendment (this “Amendment”) is being delivered to you in accordance with Section 12 of that certain Letter Agreement, dated as of October 20, 2021 (the “Letter Agreement”), by and among ExcelFin Acquisition Corp., a Delaware corpo |
|
| June 26, 2023 |
Filed by Baird Medical Investment Holdings Limited Filed by Baird Medical Investment Holdings Limited Pursuant to Rule 425 under the Securities Act of 1933 and deemed filed pursuant to Rule 14a-12 under the Securities Exchange Act of 1934 Subject Company: ExcelFin Acquisition Corp. |
|
| June 26, 2023 |
Filed by Baird Medical Investment Holdings Limited Pursuant to Rule 425 under the Securities Act of 1933 and deemed filed pursuant to Rule 14a-12 under the Securities Exchange Act of 1934 Subject Company: ExcelFin Acquisition Corp. |
|
| June 26, 2023 |
Exhibit 99.1 Baird Medical, A Leading Developer and Provider of Microwave Ablation (MWA) Medical Devices in China, to be Publicly Listed on NASDAQ through a Proposed Business Combination with ExcelFin Acquisition Corp. - Ranked first among MWA medical device providers in thyroid nodule and breast lump treatment with approximately 35% market share in China1 - Extensive distribution network with ove |
|
| June 26, 2023 |
Exhibit 2.1 BUSINESS COMBINATION AGREEMENT by and among EXCELFIN ACQUISITION CORP., BETTERS MEDICAL INVESTMENT HOLDINGS LIMITED, Baird Medical Investment Holdings Limited, Betters Medical Merger Sub, Inc. and TYCOON CHOICE GLOBAL LIMITED dated as of June 26, 2023 *Certain exhibits and the schedules to this Exhibit have been omitted in accordance with Regulation S-K Item 601(a)(5). The Registrant a |
|
| June 26, 2023 |
Exhibit 10.3 June 26, 2023 ExcelFin Acquisition Corp. 473 Jackson St., Suite 300 San Francisco, California 94111 Re: Insider Letter Amendment Ladies and Gentlemen: This amendment (this “Amendment”) is being delivered to you in accordance with Section 12 of that certain Letter Agreement, dated as of October 20, 2021 (the “Letter Agreement”), by and among ExcelFin Acquisition Corp., a Delaware corpo |
|
| June 26, 2023 |
Baird Medical Baird Medical Baird Medical INVESTOR PRESENTATION JUNE 2023 Exhibit 99.2 Baird Medical Baird Medical Baird Medical INVESTOR PRESENTATION JUNE 2023 Baird Medical This presentation (together with oral statements made in connection herewith, this “Presentation”) is for informational purposes only to assist interested parties in making their own evaluation with respect to the proposed business combination (the “Business Combination”) between ExcelFin Acquisiti |
|
| June 26, 2023 |
Exhibit 10.2 SPONSOR SUPPORT AGREEMENT THIS SPONSOR SUPPORT AGREEMENT, dated as of June 26, 2023 (this “Agreement”), is made and entered into by and among ExcelFin SPAC LLC, a Delaware limited liability company (the “Sponsor”), ExcelFin Acquisition Corp., a Delaware corporation (“SPAC”), and Baird Medical Investment Holdings Limited, a Cayman Islands exempted company (“PubCo”). WHEREAS, SPAC |
|
| June 26, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): June 26, 2023 ExcelFin Acquisition Corp. (Exact name of registrant as specified in its charter) Delaware 001-40933 86-2933776 (State or other jurisdiction of incorporation) (Commissio |
|
| June 26, 2023 |
Exhibit 99.1 Baird Medical, A Leading Developer and Provider of Microwave Ablation (MWA) Medical Devices in China, to be Publicly Listed on NASDAQ through a Proposed Business Combination with ExcelFin Acquisition Corp. - Ranked first among MWA medical device providers in thyroid nodule and breast lump treatment with approximately 35% market share in China1 - Extensive distribution network with ove |
|
| June 26, 2023 |
Filed by Baird Medical Investment Holdings Limited Filed by Baird Medical Investment Holdings Limited Pursuant to Rule 425 under the Securities Act of 1933 and deemed filed pursuant to Rule 14a-12 under the Securities Exchange Act of 1934 Subject Company: ExcelFin Acquisition Corp. |
|
| June 26, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): June 26, 2023 ExcelFin Acquisition Corp. (Exact name of registrant as specified in its charter) Delaware 001-40933 86-2933776 (State or other jurisdiction of incorporation) (Commissio |
|
| June 26, 2023 |
Baird Medical Baird Medical Baird Medical INVESTOR PRESENTATION JUNE 2023 Exhibit 99.2 Baird Medical Baird Medical Baird Medical INVESTOR PRESENTATION JUNE 2023 Baird Medical This presentation (together with oral statements made in connection herewith, this “Presentation”) is for informational purposes only to assist interested parties in making their own evaluation with respect to the proposed business combination (the “Business Combination”) between ExcelFin Acquisiti |
|
| June 8, 2023 |
Amended and Restated Promissory Note THIS PROMISSORY NOTE (“NOTE”) HAS NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”). |
|
| June 8, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): June 8, 2023 ExcelFin Acquisition Corp. (Exact name of registrant as specified in its charter) Delaware 001-40933 86-2933776 (State or other jurisdiction of incorporation) (Commission |
|
| May 19, 2023 |
s UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q Table of Contents s UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D. |
|
| May 16, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 SEC File Number 001-40933 CUSIP Number 30069X102 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D. |
|
| May 10, 2023 |
US30069X1028 / ExcelFin Acquisition Corp. / Exos Asset Management LLC Passive Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. |
|
| April 24, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G* (Rule 13d-102) INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO § 240.13d-1(b), (c), AND (d) AND AMENDMENTS THERETO FILED PURSUANT TO § 240.13d-2 (Amendment No. ) ExcelFin Acquisition Corp. (Name of Issuer) Class A ordinary shares, par value $0.0001 per share (Title of Class of Securities) 30069X102 (CU |
|
| April 20, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): April 18, 2023 ExcelFin Acquisition Corp. (Exact name of registrant as specified in its charter) Delaware 001-40933 86-2933776 (State or other jurisdiction of incorporation) (Commissi |
|
| April 19, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): April 19, 2023 (April 13, 2023) ExcelFin Acquisition Corp. (Exact name of registrant as specified in its charter) Delaware 001-40933 86-2933776 (State or other jurisdiction of incorpo |
|
| April 6, 2023 |
Entry into a Material Definitive Agreement, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): April 6, 2023 ExcelFin Acquisition Corp. (Exact name of registrant as specified in its charter) Delaware 001-40933 86-2933776 (State or other jurisdiction of incorporation) (Commissio |
|
| March 30, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2022 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 001-409 |
|
| March 24, 2023 |
Form of Non-Redemption Agreement Exhibit 10.1 FORM OF NON-REDEMPTION AGREEMENT AND ASSIGNMENT OF ECONOMIC INTEREST This Non-Redemption Agreement and Assignment of Economic Interest (this “Agreement”) is entered as of , 2023 by and among ExcelFin Acquisition Corp. (“ExcelFin”), ExcelFin SPAC LLC (the “Sponsor”) and the undersigned investor (“Investor”). RECITALS WHEREAS, the Sponsor currently holds all of the shares of Class B com |
|
| March 24, 2023 |
Entry into a Material Definitive Agreement, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): March 24, 2023 ExcelFin Acquisition Corp. (Exact name of registrant as specified in its charter) Delaware 001-40933 86-2933776 (State or other jurisdiction of incorporation) (Commissi |
|
| March 24, 2023 |
DEF 14A 1 tm238970-2def14a.htm DEF 14A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential for Use of the Commission Only (as permitted by Rule 14a |
|
| March 15, 2023 |
ExcelFin Acquisition Corp. 473 Jackson St., Suite 300 San Francisco, CA 94111 March 15, 2023 Via Overnight Courier and EDGAR U.S. Securities and Exchange Commission Division of Corporation Finance Office of Real Estate & Construction 100 F Street, N.E. Washington, D.C. 20549-3628 Attention: Catherine De Lorenzo and Brigitte Lippmann Re: ExcelFin Acquisition Corp. Preliminary Proxy Statement on Sch |
|
| March 9, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by Registrant x Filed by a Party other than the Registrant ¨ Check the appropriate box: x Preliminary Proxy Statement ¨ Confidential for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ¨ Definitive Proxy Statement |
|
| February 14, 2023 |
US30069X2018 / ExcelFin Acquisition Corp. / Sculptor Capital LP - SC 13G/A Passive Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 2)* EXCELFIN ACQUISITION CORP. (Name of Issuer) Class A Common Stock, par value $0.0001 per share (Title of Class of Securities) 30069X201 (CUSIP Number) December 31, 2022 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to d |
|
| November 14, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q Table of Contents ? ? UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D. |
|
| September 1, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): August 31, 2022 (August 26, 2022) ExcelFin Acquisition Corp. (Exact name of registrant as specified in its charter) Delaware 001-40933 86-2933776 (State or other jurisdiction of incor |
|
| September 1, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q/A Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q/A (MARK ONE) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarter ended June 30, 2022 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 001-40933 EX |
|
| August 26, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. )* ExcelFin Acquisition Corp (Name of Issuer) Common Stock, $0.0001 par value (Title of Class of Securities) 30069X102 (CUSIP Number) August 17, 2022 (Date of Event which Requires Filing of this Statement) Check the appropriate box to designate the rule purs |
|
| August 15, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q Table of Contents ? ? UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D. |
|
| May 13, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (MARK ONE) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarter ended March 31, 2022 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 001-40933 EXC |
|
| March 31, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K Table of Contents ? ? UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D. |
|
| March 31, 2022 |
EX-10.11 3 xfin-20211231xex10d11.htm EXHIBIT 10.11 Exhibit 10.11 ExcelFin Acquisition Corp. 473 Jackson St., Suite 300 San Francisco, CA 94111 March 29, 2022 Fin Venture Capital 473 Jackson St., Suite 300 San Francisco, CA 94111 Re: Financial Services Agreement Ladies and Gentlemen: On October 20, 2021, ExcelFin Acquisition Corp., a Delaware corporation (the “Company”), and Fin Venture Capital (th |
|
| March 31, 2022 |
Exhibit 4.6 DESCRIPTION OF SECURITIES OF EXCELFIN ACQUISITION CORP. REGISTERED PURSUANT TO SECTION 12 OF THE SECURITIES EXCHANGE ACT OF 1934 As of December 31, 2021, ExcelFin Acquisition Corp. (the “Company,” “we,” “us” and “our”) had three classes of securities registered under Section 12 of the Securities Exchange Act of 1934, as amended (the “Act”): Units, consisting of one share of Class A com |
|
| February 14, 2022 |
XFIN / ExcelFin Acquisition Corp - Class A / Sculptor Capital LP - SC 13G/A Passive Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 1)* EXCELFIN ACQUISITION CORP. (Name of Issuer) Class A Common Stock, par value $0.0001 per share (Title of Class of Securities) 30069X102 (CUSIP Number) December 31, 2021 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to d |
|
| February 9, 2022 |
US30069X2018 / ExcelFin Acquisition Corp. / ExcelFin SPAC LLC - SC 13G Passive Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. )* ExcelFin Acquisition Corp. (Name of Issuer) Class A Common Stock, par value of $0.0001 per share (Title of Class of Securities) 30069X201 (CUSIP Number) December 31, 2021 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to |
|
| December 10, 2021 |
Exhibit 99.1 ExcelFin Acquisition Corp. Announces the Separate Trading of its Class A Common Stock and Warrants, Commencing December 13, 2021 San Francisco, CALIFORNIA, December 10, 2021 ? ExcelFin Acquisition Corp. (Nasdaq: XFIN) (the ?Company?) announced today that commencing December 13, 2021, holders of the units sold in the Company?s initial public offering of 23,000,000 units may elect to se |
|
| December 10, 2021 |
Financial Statements and Exhibits, Other Events UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): December 10, 2021 ExcelFin Acquisition Corp. (Exact name of registrant as specified in its charter) Delaware 001-40933 86-2933776 (State or other jurisdiction of incorporation) (Commi |
|
| December 6, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (MARK ONE) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarter ended September 30, 2021 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 001-40933 |
|
| October 29, 2021 |
Financial Statements and Exhibits, Other Events UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): October 25, 2021 (October 29, 2021) ExcelFin Acquisition Corp. (Exact name of registrant as specified in its charter) Delaware 001-40933 86-2933776 (State or other jurisdiction of inc |
|
| October 29, 2021 |
ExcelFin Acquisition Corp. INDEX TO FINANCIAL STATEMENT EX-99.1 2 tm2131416d1ex99-1.htm EXHIBIT 99.1 Exhibit 99.1 ExcelFin Acquisition Corp. INDEX TO FINANCIAL STATEMENT Page Report of Independent Registered Public Accounting Firm F-2 Balance Sheet as of October 25, 2021 F-3 Notes to Balance Sheet F-4 F-1 REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM To the Shareholders and Board of Directors of ExcelFin Acquisition Corp. Opinion on the Finan |
|
| October 28, 2021 |
SC 13G 1 d243616dsc13g.htm SC 13G UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. )* EXCELFIN ACQUISITION CORP. (Name of Issuer) Class A Common Stock, par value $0.0001 per share (Title of Class of Securities) 30069X201 (CUSIP Number) October 21, 2021 (Date of Event Which Requires Filing of this Statement |
|
| October 26, 2021 |
Exhibit 10.3 Execution Version REGISTRATION RIGHTS AGREEMENT October 20, 2021 THIS REGISTRATION RIGHTS AGREEMENT (this “Agreement”), dated as of October 20, 2021, is made and entered into by and among ExcelFin Acquisition Corp., a Delaware corporation (the “Company”), ExcelFin SPAC LLC, a Delaware limited liability company (the “Sponsor”), and the other parties listed on the signature pages hereto |
|
| October 26, 2021 |
Exhibit 10.6 SPONSOR WARRANTS PURCHASE AGREEMENT October 20, 2021 THIS SPONSOR WARRANTS PURCHASE AGREEMENT (as it may from time to time be amended and including all exhibits referenced herein, this ?Agreement?), dated as of October 20, 2021, is entered into by and between ExcelFin Acquisition Corp., a Delaware corporation (the ?Company?), and ExcelFin SPAC LLC, a Delaware limited liability company |
|
| October 26, 2021 |
EX-10.7 12 tm2114962d14ex10-7.htm EXHIBIT 10.7 Exhibit 10.7 Execution Version FORWARD PURCHASE AGREEMENT This Forward Purchase Agreement (this “Agreement”) is entered into as of October 20, 2021, by and between ExcelFin Acquisition Corp., a blank check company incorporated as a Delaware corporation (the “Company”), and Fin VC Constellation, LLC and Grand Fortune Capital LLC (each individually, a “ |
|
| October 26, 2021 |
Exhibit 10.1 Execution Version LETTER AGREEMENT Dated October 20, 2021 This letter agreement (this ?Letter Agreement?) is entered into by and among ExcelFin Acquisition Corp., a Delaware corporation (the ?Company?), ExcelFin SPAC LLC, a Delaware limited liability company (the ?Sponsor?), and each other undersigned person (each such other undersigned person, an ?Insider? and collectively, the ?Insi |
|
| October 26, 2021 |
ExcelFin Acquisition Corp. Announces Pricing of $200 Million Initial Public Offering Exhibit 99.1 ExcelFin Acquisition Corp. Announces Pricing of $200 Million Initial Public Offering San Francisco, CALIFORNIA, October 20, 2021 – ExcelFin Acquisition Corp. (Nasdaq: XFIN) (the “Company”) announced today the pricing of its initial public offering (“IPO”) of 20,000,000 units at price of $10.00 per unit. The units are expected to be listed on The Nasdaq Global Market (“NASDAQ”) and tra |
|
| October 26, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): October 26, 2021 (October 20, 2021) ExcelFin Acquisition Corp. (Exact name of registrant as specified in its charter) Delaware 001-40933 86-2933776 (State or other jurisdiction of inc |
|
| October 26, 2021 |
Exhibit 10.4 ExcelFin Acquisition Corp. 473 Jackson St., Suite 300 San Francisco, CA 94111 October 20, 2021 ExcelFin SPAC LLC 473 Jackson St., Suite 300 San Francisco, CA 94111 Re: Administrative Services Agreement Ladies and Gentlemen: This letter agreement by and between ExcelFin Acquisition Corp., a Delaware corporation (the ?Company?), and ExcelFin SPAC LLC, a Delaware limited liability compan |
|
| October 26, 2021 |
Exhibit 10.8 INDEMNITY AGREEMENT October 20, 2021 THIS INDEMNITY AGREEMENT (this “Agreement”) is made as of October 20, 2021, by and between ExcelFin Acquisition Corp., a Delaware corporation (the “Company”), and [●] (“Indemnitee”). RECITALS WHEREAS, highly competent persons have become more reluctant to serve publicly-held corporations as directors, officers or in other capacities unless they are |
|
| October 26, 2021 |
Exhibit 3.1 Delaware The First State Page 1 I, JEFFREY W. BULLOCK, SECRETARY OF STATE OF THE STATE OF DELAWARE, DO HEREBY CERTIFY THE ATTACHED IS A TRUE AND CORRECT COPY OF THE RESTATED CERTIFICATE OF ?EXCELFIN ACQUISITION CORP.?, FILED IN THIS OFFICE ON THE TWENTIETH DAY OF OCTOBER, A.D. 2021, AT 6:22 O`CLOCK P.M. 5500726 8100 SR# 20213570004 Authentication: 204468011 Date: 10-20-21 You may verif |
|
| October 26, 2021 |
Exhibit 10.5 ExcelFin Acquisition Corp. 473 Jackson St., Suite 300 San Francisco, CA 94111 October 20, 2021 Fin Venture Capital 473 Jackson St., Suite 300 San Francisco, CA 94111 Re: Financial Services Agreement Ladies and Gentlemen: This letter agreement by and between ExcelFin Acquisition Corp., a Delaware corporation (the “Company”), and Fin Venture Capital (the “Services Provider”), dated as o |
|
| October 26, 2021 |
EX-4.2 5 tm2114962d14ex4-2.htm EXHIBIT 4.2 Exhibit 4.2 Execution Version PRIVATE WARRANT AGREEMENT THIS PRIVATE WARRANT AGREEMENT, dated as of October 20, 2021 (as amended, supplemented or otherwise modified from time to time, this “Agreement”), is by and between ExcelFin Acquisition Corp., a Delaware corporation (the “Company”), and American Stock Transfer & Trust Company, LLC, a limited liabilit |
|
| October 26, 2021 |
Exhibit 1.1 EXECUTION VERSION EXCELFIN ACQUISITION CORP. 20,000,000 Units ($10.00 per Unit) UNDERWRITING AGREEMENT October 20, 2021 UBS Securities LLC As Representative of the several Underwriters c/o UBS Securities LLC 1285 Avenue of the Americas New York, New York 10019 Ladies and Gentlemen: ExcelFin Acquisition Corp., a Delaware corporation (the “Company”), proposes to issue and sell to the und |
|
| October 26, 2021 |
Exhibit 4.1 Execution Version PUBLIC WARRANT AGREEMENT THIS PUBLIC WARRANT AGREEMENT, dated as of October 20, 2021 (as amended, supplemented or otherwise modified from time to time, this ?Agreement?), is by and between ExcelFin Acquisition Corp., a Delaware corporation (the ?Company?), and American Stock Transfer & Trust Company, LLC, a limited liability trust company organized and existing under |
|
| October 26, 2021 |
EX-10.2 7 tm2114962d14ex10-2.htm EXHIBIT 10.2 Exhibit 10.2 Execution Version INVESTMENT MANAGEMENT TRUST AGREEMENT This Investment Management Trust Agreement (this “Agreement”) is made effective as of October 25, 2021, by and between ExcelFin Acquisition Corp., a Delaware corporation (the “Company”), and U.S. Bank National Association, a national banking association (the “Trustee”). WHEREAS, the C |
|
| October 22, 2021 |
$200,000,000 ExcelFin Acquisition Corp. 20,000,000 Units 424B4 1 tm2114962-10424b4.htm 424B4 TABLE OF CONTENTS Filed Pursuant to Rule 424(b)(4) Registration No. 333-260038 PROSPECTUS $200,000,000 ExcelFin Acquisition Corp. 20,000,000 Units ExcelFin Acquisition Corp. is a newly incorporated blank check company formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business comb |
|
| October 19, 2021 |
8-A12B 1 tm2114962d138a12b.htm 8-A12B UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-A FOR REGISTRATION OF CERTAIN CLASSES OF SECURITIES PURSUANT TO SECTION 12(b) OR (g) OF THE SECURITIES EXCHANGE ACT OF 1934 EXCELFIN ACQUISITION CORP. (Exact Name of Registrant as Specified in Its Charter) Delaware 86-2933776 (State or other jurisdiction of incorporation or organiza |
|
| October 18, 2021 |
ExcelFin Acquisition Corp. 473 Jackson St., Suite 300 San Francisco, CA 94111 ExcelFin Acquisition Corp. 473 Jackson St., Suite 300 San Francisco, CA 94111 October 18, 2021 VIA EDGAR Division of Corporation Finance Office of Real Estate & Construction U.S. Securities and Exchange Commission 100 F Street, NE Washington, D.C. 20549 Attention: Maryse Mills-Apenteng Re: ExcelFin Acquisition Corp. Registration Statement on Form S-1 Filed October 5, 2021, as amended File No. 333- |
|
| October 18, 2021 |
* * * [Signature Page Follows] CORRESP 1 filename1.htm October 18, 2021 VIA EDGAR United States Securities and Exchange Commission Division of Corporation Finance 100 F Street, N.E. Washington, D.C. 20549 Attention: Maryse Mills-Apenteng Re: ExcelFin Acquisition Corp. Registration Statement on Form S-1 Filed October 5, 2021, as amended File No. 333-260038 Dear Sir or Madam: Pursuant to Rule 461 of the General Rules and Regulati |
|
| October 15, 2021 |
Form of Underwriting Agreement Exhibit 1.1 EXCELFIN ACQUISITION CORP. 20,000,000 Units ($10.00 per Unit) UNDERWRITING AGREEMENT [●], 2021 UBS Securities LLC As Representative of the several Underwriters c/o UBS Securities LLC 1285 Avenue of the Americas New York, New York 10019 Ladies and Gentlemen: ExcelFin Acquisition Corp., a Delaware corporation (the “Company”), proposes to issue and sell to the underwriters named in Schedu |
|
| October 15, 2021 |
As filed with the Securities and Exchange Commission on October 14, 2021 S-1/A 1 tm2114962-8s1a.htm S-1/A TABLE OF CONTENTS As filed with the Securities and Exchange Commission on October 14, 2021 Registration No. 333-260038 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Amendment No. 1 to FORM S-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 ExcelFin Acquisition Corp. (Exact name of registrant as specified in its charter) Delaware ( |
|
| October 15, 2021 |
Exhibit 10.3 FORM OF INVESTMENT MANAGEMENT TRUST AGREEMENT This Investment Management Trust Agreement (this ?Agreement?) is made effective as of [ ], 2021, by and between ExcelFin Acquisition Corp., a Delaware corporation (the ?Company?), and U.S. Bank National Association, a national banking association (the ?Trustee?). WHEREAS, the Company?s registration statement on Form S-1 (the ?Registration |
|
| October 15, 2021 |
Exhibit 10.10 ExcelFin Acquisition Corp. 473 Jackson St., Suite 300 San Francisco, CA 94111 [●], 2021 Fin Venture Capital 473 Jackson St., Suite 300 San Francisco, CA 94111 Re: Financial Services Agreement Ladies and Gentlemen: This letter agreement by and between ExcelFin Acquisition Corp., a Delaware corporation (the “Company”), and Fin Venture Capital (the “Services Provider”), dated as of the |
|
| October 5, 2021 |
Exhibit 4.5 FORM OF PRIVATE WARRANT AGREEMENT THIS PRIVATE WARRANT AGREEMENT, dated as of [ ], 2021 (as amended, supplemented or otherwise modified from time to time, this “Agreement”), is by and between ExcelFin Acquisition Corp., a Delaware corporation (the “Company”), and American Stock Transfer & Trust Company, LLC, a limited liability trust company organized and existing under the laws of the |
|
| October 5, 2021 |
Exhibit 99.2 CONSENT OF NEIL WOLFSON In connection with the filing by ExcelFin Acquisition Corp. (the “Company”) of its Registration Statement (the “Registration Statement”) on Form S-1 with the Securities and Exchange Commission under the Securities Act of 1933, as amended (the “Securities Act”), I hereby consent, pursuant to Rule 438 of the Securities Act, to being named as a nominee to the boar |
|
| October 5, 2021 |
EX-10.1 10 tm2114962d7ex10-1.htm EXHIBIT 10.1 Exhibit 10.1 THIS PROMISSORY NOTE (THIS “NOTE”) HAS NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”). THIS NOTE HAS BEEN ACQUIRED FOR INVESTMENT ONLY AND MAY NOT BE SOLD, TRANSFERRED OR ASSIGNED IN THE ABSENCE OF REGISTRATION OF THE RESALE THEREOF UNDER THE SECURITIES ACT OR AN OPINION OF COUNSEL REASONABLY SATISF |
|
| October 5, 2021 |
Exhibit 4.1 SPECIMEN UNIT CERTIFICATE NUMBER UNITS U- SEE REVERSE FOR CERTAIN DEFINITIONS CUSIP EXCELFIN ACQUISITION CORP. UNITS CONSISTING OF ONE SHARE OF CLASS A COMMON STOCK AND ONE-HALF OF ONE WARRANT TO PURCHASE ONE SHARE OF CLASS A COMMON STOCK THIS CERTIFIES THAT is the owner of Units. Each Unit (“Unit”) consists of one (1) share of Class A common stock, par value $0.0001 per share (“Common |
|
| October 5, 2021 |
EX-10.5 14 tm2114962d7ex10-5.htm EXHIBIT 10.5 Exhibit 10.5 EXCELFIN ACQUISITION CORP. 473 Jackson Street, Suite 300 San Francisco, CA 94111 ExcelFin SPAC LLC March 15, 2021 473 Jackson Street, Suite 300 San Francisco, CA 94111 RE: Securities Subscription Agreement for Founder Shares Ladies and Gentlemen: ExcelFin Acquisition Corp., a Delaware corporation (the “Company”), is pleased to accept the o |
|
| October 5, 2021 |
Exhibit 10.7 INDEMNITY AGREEMENT [●], 2021 THIS INDEMNITY AGREEMENT (this “Agreement”) is made as of [●], 2021, by and between ExcelFin Acquisition Corp., a Delaware corporation (the “Company”), and [●] (“Indemnitee”). RECITALS WHEREAS, highly competent persons have become more reluctant to serve publicly-held corporations as directors, officers or in other capacities unless they are provided with |
|
| October 5, 2021 |
Exhibit 10.8 ExcelFin Acquisition Corp. 473 Jackson St., Suite 300 San Francisco, CA 94111 [●], 2021 ExcelFin SPAC LLC 473 Jackson St., Suite 300 San Francisco, CA 94111 Re: Administrative Services Agreement Ladies and Gentlemen: This letter agreement by and between ExcelFin Acquisition Corp., a Delaware corporation (the “Company”), and ExcelFin SPAC LLC, a Delaware limited liability company (the |
|
| October 5, 2021 |
Form of Code of Ethics and Business Conduct Exhibit 14 CODE OF ETHICS OF EXCELFIN ACQUISITION CORP. 1. Introduction The Board of Directors (the “Board”) of ExcelFin Acquisition Corp. has adopted this code of ethics (this “Code”), as amended from time to time by the Board and which is applicable to all of the Company’s directors, officers and employees to: · promote honest and ethical conduct, including the ethical handling of actual or appa |
|
| October 5, 2021 |
Form of Amended and Restated Certificate of Incorporation Exhibit 3.2 AMENDED AND RESTATED CERTIFICATE OF INCORPORATION OF EXCELFIN ACQUISITION CORP. [●], 2021 ExcelFin Acquisition Corp., a corporation organized and existing under the laws of the State of Delaware (the “Corporation”), DOES HEREBY CERTIFY AS FOLLOWS: 1. The name of the Corporation is ExcelFin Acquisition Corp. 2. The original certificate of incorporation of the Corporation was filed with |
|
| October 5, 2021 |
Exhibit 4.4 FORM OF PUBLIC WARRANT AGREEMENT THIS PUBLIC WARRANT AGREEMENT, dated as of [ ], 2021 (as amended, supplemented or otherwise modified from time to time, this “Agreement”), is by and between ExcelFin Acquisition Corp., a Delaware corporation (the “Company”), and American Stock Transfer & Trust Company, LLC, a limited liability trust company organized and existing under the laws of the S |
|
| October 5, 2021 |
Exhibit 99.3 CONSENT OF GO LIN PAO In connection with the filing by ExcelFin Acquisition Corp. (the “Company”) of its Registration Statement (the “Registration Statement”) on Form S-1 with the Securities and Exchange Commission under the Securities Act of 1933, as amended (the “Securities Act”), I hereby consent, pursuant to Rule 438 of the Securities Act, to being named as a nominee to the board |
|
| October 5, 2021 |
EX-3.3 4 tm2114962d7ex3-3.htm EXHIBIT 3.3 Exhibit 3.3 BYLAWS OF EXCELFIN ACQUISITION CORP. ARTICLE I OFFICES Section 1.1 Registered Office. The registered office of ExcelFin Acquisition Corp., a Delaware corporation (the “Corporation”), within the State of Delaware shall be located at either (a) the principal place of business of the Corporation in the State of Delaware or (b) the office of the co |
|
| October 5, 2021 |
Exhibit 99.1 CONSENT OF GARY MELZER In connection with the filing by ExcelFin Acquisition Corp. (the “Company”) of its Registration Statement (the “Registration Statement”) on Form S-1 with the Securities and Exchange Commission under the Securities Act of 1933, as amended (the “Securities Act”), I hereby consent, pursuant to Rule 438 of the Securities Act, to being named as a nominee to the board |
|
| October 5, 2021 |
EX-4.2 6 tm2114962d7ex4-2.htm EXHIBIT 4.2 Exhibit 4.2 SPECIMEN CLASS A COMMON STOCK CERTIFICATE NUMBER NUMBER C- SHARES SEE REVERSE FOR CERTAIN DEFINITIONS CUSIP EXCELFIN ACQUISITION CORP. INCORPORATED UNDER THE LAWS OF THE STATE OF DELAWARE CLASS A COMMON STOCK This Certifies that is the owner of FULLY PAID AND NON-ASSESSABLE SHARES OF THE PAR VALUE OF $0.0001 EACH OF THE CLASS A COMMON STOCK OF |
|
| October 5, 2021 |
Form of Registration Rights Agreement between the Registrant and certain security holders Exhibit 10.4 REGISTRATION RIGHTS AGREEMENT [●], 2021 THIS REGISTRATION RIGHTS AGREEMENT (this “Agreement”), dated as of [●], 2021, is made and entered into by and among ExcelFin Acquisition Corp., a Delaware corporation (the “Company”), ExcelFin SPAC LLC, a Delaware limited liability company (the “Sponsor”), and the other parties listed on the signature pages hereto and any person or entity who he |
|
| October 5, 2021 |
Form of Letter Agreement among the Registrant and its directors and officers and ExcelFin SPAC LLC Exhibit 10.2 LETTER AGREEMENT Dated [●], 2021 This letter agreement (this “Letter Agreement”) is entered into by and among ExcelFin Acquisition Corp., a Delaware corporation (the “Company”), ExcelFin SPAC LLC, a Delaware limited liability company (the “Sponsor”), and each other undersigned person (each such other undersigned person, an “Insider” and collectively, the “Insiders”). Reference is made |
|
| October 5, 2021 |
Power of Attorney (included on signature page to the initial filing of this Registration Statement) S-1 1 tm2114962-6s1.htm S-1 TABLE OF CONTENTS As filed with the Securities and Exchange Commission on October 4, 2021 Registration No. 333- UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM S-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 ExcelFin Acquisition Corp. (Exact name of registrant as specified in its charter) Delaware (State or other jurisdicti |
|
| October 5, 2021 |
Exhibit 3.1 Delaware The First State Page 1 I, JEFFREY W. BULLOCK, SECRETARY OF STATE OF THE STATE OF DELAWARE, DO HEREBY CERTIFY THE ATTACHED IS A TRUE AND CORRECT COPY OF THE CERTIFICATE OF INCORPORATION OF ?EXCELFIN ACQUISITION CORP.?, FILED IN THIS OFFICE ON THE FIFTEENTH DAY OF MARCH, A.D. 2021, AT 1:37 O`CLOCK P.M. 5500726 8100 SR# 20210909642 Authentication: 202738393 Date: 03-16-21 You may |
|
| October 5, 2021 |
Exhibit 10.3 INVESTMENT MANAGEMENT TRUST AGREEMENT This Investment Management Trust Agreement (this ?Agreement?) is made effective as of [?], 2021, by and between ExcelFin Acquisition Corp., a Delaware corporation (the ?Company?), and U.S Bank National Association, a national banking association (the ?Trustee?). WHEREAS, the Company?s registration statement on Form S-1, File No. 333-[?] (the ?Regi |
|
| October 5, 2021 |
Form of Sponsor Warrants Purchase Agreement between the Registrant and ExcelFin SPAC LLC Exhibit 10.6 SPONSOR WARRANTS PURCHASE AGREEMENT [●], 2021 THIS SPONSOR WARRANTS PURCHASE AGREEMENT (as it may from time to time be amended and including all exhibits referenced herein, this “Agreement”), dated as of [●], 2021, is entered into by and between ExcelFin Acquisition Corp., a Delaware corporation (the “Company”), and ExcelFin SPAC LLC, a Delaware limited liability company (the “Purchas |
|
| October 5, 2021 |
Forward Purchase Agreement among the Registrant and the Sponsor Affiliates Exhibit 10.9 FORWARD PURCHASE AGREEMENT This Forward Purchase Agreement (this ?Agreement?) is entered into as of , 2021, by and between ExcelFin Acquisition Corp., a blank check company incorporated as a Delaware corporation (the ?Company?), and and (each individually, a ?Purchaser? and collectively, the ?Purchasers?). Recitals WHEREAS, the Company was incorporated for the purpose of effecting a m |
|
| September 10, 2021 |
DRS/A 1 filename1.htm TABLE OF CONTENTS As submitted confidentially with the U.S. Securities and Exchange Commission on September 10, 2021. This Amendment No. 2 to draft registration statement has not been publicly filed with the U.S. Securities and Exchange Commission and all information herein remains strictly confidential. Registration No. 333- UNITED STATES SECURITIES AND EXCHANGE COMMIS |
|
| September 10, 2021 |
599 Lexington Avenue New York, NY 10022-6069 599 Lexington Avenue New York, NY 10022-6069 +1.212.848.4000 September 10, 2021 Via Edgar Securities and Exchange Commission Division of Corporation Finance 100 F Street, N.E. Washington, D.C. 20549 Attention: Ameen Hamady, Isaac Esquivel, Brigitte Lippmann & Maryse Mills-Apenteng Re: ExcelFin Acquisition Corp. (the “Company”) Amendment No. 1 to Draft Registration Statement on Form S-1 Submitted S |
|
| September 3, 2021 |
FORM OF PRIVATE WARRANT AGREEMENT Exhibit 4.5 FORM OF PRIVATE WARRANT AGREEMENT THIS PRIVATE WARRANT AGREEMENT, dated as of [ ], 2021 (as amended, supplemented or otherwise modified from time to time, this ?Agreement?), is by and between ExcelFin Acquisition Corp., a Delaware corporation (the ?Company?), and Continental Stock Transfer & Trust Company, a New York limited purpose trust company, as warrant agent (the ?Warrant Agent?) |
|
| September 3, 2021 |
FORM OF PUBLIC WARRANT AGREEMENT EX-4.4 2 filename2.htm Exhibit 4.4 FORM OF PUBLIC WARRANT AGREEMENT THIS PUBLIC WARRANT AGREEMENT, dated as of [ ], 2021 (as amended, supplemented or otherwise modified from time to time, this “Agreement”), is by and between ExcelFin Acquisition Corp., a Delaware corporation (the “Company”), and Continental Stock Transfer & Trust Company, a New York limited purpose trust company, as warrant agent |
|
| September 3, 2021 |
DRS/A 1 filename1.htm TABLE OF CONTENTS As submitted confidentially with the U.S. Securities and Exchange Commission on September 3, 2021. This Amendment No. 1 to draft registration statement has not been publicly filed with the U.S. Securities and Exchange Commission and all information herein remains strictly confidential. Registration No. 333- UNITED STATES SECURITIES AND EXCHANGE COMMISS |
|
| May 21, 2021 |
DRS 1 filename1.htm TABLE OF CONTENTS As submitted confidentially with the U.S. Securities and Exchange Commission on May 21, 2021. This draft registration statement has not been publicly filed with the U.S. Securities and Exchange Commission and all information herein remains strictly confidential. Registration No. 333- UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 |
